Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?  Adeera Levin, Y.A.N. Chun Li  Kidney International 

Slides:



Advertisements
Similar presentations
Volume 69, Issue 1, Pages (January 2006)
Advertisements

A.M. Thompson, T.G. Pickering  Kidney International 
Long-term evolution of cardiomyopathy in dialysis patients
Beta blockers in the management of chronic kidney disease
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation  Jordi Bover,
Plasma sodium and hypertension
Intensive hemodialysis—keeping the faith
Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta 
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward  Adeera Levin, Paul E. Stevens  Kidney International 
Volume 70, Issue 8, Pages (October 2006)
Renal vitamin D receptor expression and vitamin D renoprotection
Anemia management in chronic kidney disease
FGF23 or PTH: which comes first in CKD ?
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Intensive hemodialysis—keeping the faith
C-reactive protein and dialysis access
Chapter 3: Management of progression and complications of CKD
Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta 
Hung-Chun Chen, Jinn-Yuh Guh, Juei-Hsiung Tsai, Yung-Hsiung Lai 
Homocysteine and risk in end-stage renal disease: a matter of context
George A. Kaysen, Burl R. Don
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
This Month in AJKD American Journal of Kidney Diseases
Use of vitamin D in chronic kidney disease patients
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.
Volume 72, Issue 8, Pages (October 2007)
The calcium–phosphorus in guidelines for CKD-MBD
Volume 63, Pages S6-S9 (June 2003)
Relationship between methylmalonic acid and cobalamin in uremia
Anemia as a risk factor for cardiovascular disease
Blood pressure targets in hemodialysis patients
Volume 67, Issue 1, Pages (January 2005)
Role of vitamin D receptor activators on cardiovascular risk
Volume 56, Pages S31-S37 (December 1999)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 56, Issue 5, Pages (November 1999)
Calcium sensing in podocytes
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Long-term evolution of cardiomyopathy in dialysis patients
Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter  Richard A. Zager, Ali C.M. Johnson,
Chien-Te Lee, Viet M. Huynh, Li-Wen Lai, Yeong-Hau H. Lien 
Volume 87, Issue 5, Pages (May 2015)
Volume 68, Issue 5, Pages (November 2005)
Volume 64, Issue 2, Pages (August 2003)
Leptin and inflammation-associated cachexia in chronic kidney disease
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 69, Issue 1, Pages (January 2006)
Cardiovascular risk in chronic kidney disease
Pathophysiology of cardiovascular disease in hemodialysis patients
Is complement a target for therapy in renal disease?
Volume 74, Issue 9, Pages (November 2008)
Recent developments in the management of secondary hyperparathyroidism
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Vitamin D deficiency and anemia in early chronic kidney disease
Cell cycle regulation: Repair and regeneration in acute renal failure
Strategies for iron supplementation: Oral versus intravenous
Antioxidant therapy in hemodialysis patients: a systematic review
Volume 75, Issue 8, Pages (April 2009)
The cost of starting and maintaining a large home hemodialysis program
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Volume 62, Issue 5, Pages (November 2002)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?  Adeera Levin, Y.A.N. Chun Li  Kidney International  Volume 68, Issue 5, Pages 1973-1981 (November 2005) DOI: 10.1111/j.1523-1755.2005.00651.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Inverse relationship between plasma matrix metalloproteinase 9 (MMP-9) levels and vitamin D status (25-hydroxyvitamin D). These data were obtained from apparently healthy subjects of Bangladeshi origin living in London, United Kingdom (from Timms et al, Q J Med 95:787-796, 2002, with permission). Kidney International 2005 68, 1973-1981DOI: (10.1111/j.1523-1755.2005.00651.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Changes of left ventricular mass (LVM) index before and after calcitriol therapy in hemodialysis patients with secondary hyperparathyroidism. The patients received intravenous injection of calcitriol for 15 weeks (from Park et al, Am J Kidney Dis 33:73-81, 1999, with permission). Kidney International 2005 68, 1973-1981DOI: (10.1111/j.1523-1755.2005.00651.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Inverse relationship between plasma renin activity and 1,25-dihydroxyvitmain D levels in patients with essential hypertension (from Resnick et al, Ann Intern Med 105:649-654, 1986, with permission). Kidney International 2005 68, 1973-1981DOI: (10.1111/j.1523-1755.2005.00651.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Stimulation of the renin-angiotensin system in mutant mice lacking either the vitamin D receptor (VDR) gene or the 25-hydroxyvitamin D 1α-hydroxylase (1α-hyd) gene. A marked increase in renin mRNA transcript was seen in both vitamin D receptor knockout mice (A) and 1α-hydroxylase knockout mice (B). Left panels are Northern blot, and right panels are PhosphorImager quantitative results of renin mRNA levels detected by Northern blot analysis. *P < 0.01 vs. wild-type mice. Kidney International 2005 68, 1973-1981DOI: (10.1111/j.1523-1755.2005.00651.x) Copyright © 2005 International Society of Nephrology Terms and Conditions